校際選修

115-1 選課時程

進行中

  • 初選第一階段 6/15/2026
  • 初選第二階段 6/22/2026
  • 校際選修 8/24/2026
  • 初選第三階段 8/31/2026
  • 開學後加退選 9/7/2026
  • 逾期加退選 9/21/2026
選課資源

選擇性內放射治療

Selective Internal Radiation Therapy

學期
112-2
學分
2 學分
當期課號
132518
永久課號
BEIR30067
開課單位
生物醫學影像暨放射科學系
授課教師
吳東信
校區
陽明
類別
選修
上課時間表
週三
7
15:30–16:20
選擇性內放射治療
YB458
2 節連堂
8
16:30–17:20

* 根據陽明交大上課時間表所列

概述

選擇性內部放射治療(Selective Internal Radiation Therapy, SIRT)為動脈內微近距離放射治療,是一種用於介入放射學治療肝癌的放射治療形式,也稱為經動脈放射栓塞術(Transarterial Radioembolization, TARE)。它通常適用於手術無法切除的癌症患者,尤其是肝細胞癌或肝轉移癌患者。該治療包括將微小的放射性物質微球注射到為腫瘤供血的動脈中,這些微球會停留在腫瘤的小血管中。由於這種治療將放射治療與栓塞相結合,因此稱為放射栓塞(Radioembolization, RE)。本課程旨在簡要回顧肝臟選擇性內部放射治療的當前臨床狀況和挑戰,並概述用不同放射性核素的優缺點。 Selective internal radiation therapy (SIRT), is a form of radiation therapy used in interventional radiology to treat liver cancer with intra-arterial microbrachytherapy, also known as transarterial radioembolization (TARE). It is generally for selected patients with surgically unresectable cancers, especially hepatocellular carcinoma or metastasis to the liver. The treatment involves injecting tiny microspheres of radioactive material into the arteries that supply the tumor, where the spheres lodge in the small vessels of the tumor. Because this treatment combines radiotherapy with embolization, it is called radioembolization. This class aims to briefly review the current clinical status and challenges in liver radioembolization therapy as well as to outline the advantages and disadvantages of different radionuclides used for this purpose.

教學方式

(1) Textbook: Radiopharmaceuticals for Therapy Author: F. F. (Russ) Knapp • Ashutosh Dash ISBN: 978-81-322-2606-2 Language: English (2) Textbook: Liver Radioembolization with 90Y Microspheres (Second Edition) Author: Jose ́ Ignacio Bilbao • Maximilian F. Reiser J ISBN: 978-3-642-36473-0 (eBook) Language: English (3) Textbook: Handbook of Radioembolization Author: Alexander S. Pasciak, J. Mark McKinney, Yong C. Bradley ISBN: 978-1-4987-4201-6 Language: English

評分方式

課堂參與情形 20% 期中考試40% 期未考試40% 書面報告0% 期未報告0%

週次計畫
週次主題
第 1 週Introduction
第 2 週Clinical Advances and Challenges
第 3 週Y-90microsphere Pre-treatment Safety Procedure
第 4 週Post-Treatment Dosimetry
第 5 週Tumor Predictive Dosimetry and Dose-response
第 6 週HCC Clinical Practice Guidelines (1 & 2)
第 7 週HCC Clinical Practice Guidelines (1 & 2)
第 8 週Large Randomized Controlled Trials
第 9 週TARE vs. TACE
第 10 週Liver Transplantation Following TARE
第 11 週Strategies for Safer Liver Surgery (1 & 2)
第 12 週BCLC 2022
第 13 週The Physics and Radiobiologic Models
第 14 週The Physics and Radiobiologic Models
第 15 週Hepatic Structural Dosimetry
第 16 週Final Examination
第 17 週Demonstration and Discussion of Liver Radioembolization (1)
第 18 週Demonstration and Discussion of Liver Radioembolization (2)